GeneNews (GEN) Hits New 12-Month Low at $0.04
GeneNews Ltd (TSE:GEN)’s share price reached a new 52-week low during mid-day trading on Monday . The stock traded as low as C$0.04 and last traded at C$0.04, with a volume of 267000 shares changing hands. The stock had previously closed at C$0.04.
About GeneNews (TSE:GEN)
GeneNews Limited focuses on developing and commercializing proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications. Its proprietary platform technology, the Sentinel Principle, identifies novel biomarkers from whole blood.
Further Reading: Investing strategies using the yield curve
Receive News & Ratings for GeneNews Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GeneNews and related companies with MarketBeat.com's FREE daily email newsletter.